Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. GeneDx Holdings Corp shares valued at $836,200 were purchased by Kevin Feeley on Mar 26 ’25. At $95.61 per share, Kevin Feeley acquired 8,746 shares.
Also, Katherine Stueland purchased 46,551 shares, netting a total of over 4,451,200 in proceeds.
Before that, Stueland Katherine had sold 10,559 shares from its account. In a trade valued at $1,021,146, the Chief Executive Officer traded GeneDx Holdings Corp shares for $96.71 each. Upon closing the transaction, the insider’s holdings decreased to 10,559 shares, worth approximately $1.43 million.
As published in their initiating research note from Wells Fargo on August 28, 2024, GeneDx Holdings Corp [WGS] has been an Equal weight and the price target has been revised to $34. Analysts at Craig Hallum started covering the stock with ‘”a Buy”‘ outlook in a report released in early July.
Analyzing WGS Stock Performance
During the last five days, there has been a drop of approximately -1.03%. Over the course of the year, GeneDx Holdings Corp shares have jumped approximately 25.47%. Shares of the company reached a 52-week high of $115.60 on 02/19/25 and a 52-week low of $58.62 on 02/07/25. A 50-day SMA is recorded $86.28, while a 200-day SMA reached $59.84.
Support And Resistance Levels for GeneDx Holdings Corp (WGS)
According to the 24-hour chart, there is a support level at 92.70, which, if violated, would cause prices to drop to 88.96. In the upper region, resistance lies at 100.71. The next price resistance is at 104.99. RSI (Relative Strength Index) is 51.85 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 4.45, which suggests the price will increase in the coming days. Percent R is at 53.02%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
